Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients

OBJECTIVES: Minimally important changes (MICs) for SPondyloArthritis Research Consortium of Canada (SPARCC) MRI scores are ⩾2.5 for SI joint and ⩾5 for spine. This post hoc analysis assessed achievement of MIC in SPARCC scores in biologic-naïve patients with AS treated with tofacitinib or placebo, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Maksymowych, Walter P, van der Heijde, Désirée, Baraliakos, Xenofon, Deodhar, Atul, Sherlock, Sarah P, Li, David, Fleishaker, Dona, Hendrikx, Thijs, Kanik, Keith S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055606/
https://www.ncbi.nlm.nih.gov/pubmed/29718421
http://dx.doi.org/10.1093/rheumatology/key104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055606/
https://www.ncbi.nlm.nih.gov/pubmed/29718421
http://dx.doi.org/10.1093/rheumatology/key104

Ejemplares similares